Skip to main content
SpringerLink
Log in

Factors Associated with Alzheimer’s Disease: An Overview of Reviews

  • Review
  • Published:
The Journal of Prevention of Alzheimer's Disease Aims and scope Submit manuscript

Abstract

Alzheimer’s disease (AD) is a frequent pathology, with a poor prognosis, for which no curative treatment is available in 2018. AD prevention is an important issue, and is an important research topic.

In this manuscript, we have synthesized the literature reviews and meta-analyses relating to modifiable risk factors associated with AD. Smoking, diabetes, high blood pressure, obesity, hypercholesterolemia, physical inactivity, depression, head trauma, heart failure, bleeding and ischemic strokes, sleep apnea syndrome appeared to be associated with an increased risk of AD. In addition to these well-known associations, we highlight here the existence of associated factors less described: hyperhomocysteinemia, hearing loss, essential tremor, occupational exposure to magnetic fields.

On the contrary, some oral antidiabetic drugs, education and intellectual activity, a Mediterranean-type diet or using Healthy Diet Indicator, consumption of unsaturated fatty acids seemed to have a protective effect.

Better knowledge of risk factors for AD allows for better identification of patients at risk. This may contribute to the emergence of prevention policies to delay or prevent the onset of AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AD:

Alzheimer’s disease

OR:

Odds-Ratio

RR:

Relative Ratio

References

  1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 2013;9:63–75.e2. doi:10.1016/j.jalz.2012.11.007.

    Article  PubMed  Google Scholar 

  2. Garre-Olmo J. [Epidemiology of Alzheimer’s disease and other dementias]. Rev Neurol 2018;66:377–86.

    CAS  PubMed  Google Scholar 

  3. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement J Alzheimers Assoc 2018};14}:367–429. doi:10.1016/j.jalz.2018.02.00

  4. Manton KC, Gu XL, Ukraintseva SV. Declining prevalence of dementia in the U.S. elderly population. Adv Gerontol Uspekhi Gerontol 2005;16:30–7.

    CAS  Google Scholar 

  5. Langa KM, Larson EB, Karlawish JH, Cutler DM, Kabeto MU, Kim SY, et al. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement J Alzheimers Assoc 2008;4:134–44. doi:10.1016/j.jalz.2008.01.001.

    Article  Google Scholar 

  6. Rocca WA, Petersen RC, Knopman DS, Hebert LE, Evans DA, Hall KS, et al. Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimers Dement J Alzheimers Assoc 2011;7:80–93. doi:10.1016/j.jalz.2010.11.002.

    Article  Google Scholar 

  7. Satizabal CL, Beiser AS, Chouraki V, Chêne G, Dufouil C, Seshadri S. Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med 2016;374:523–32. doi:10.1056/NEJMoa1504327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Grasset L, Brayne C, Joly P, Jacqmin-Gadda H, Peres K, Foubert-Samier A, et al. Trends in dementia incidence: Evolution over a 10-year period in france. Alzheimers Dement 2015;11:P219–20. doi:10.1016/j.jalz.2015.07.243.

    Article  Google Scholar 

  9. Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, et al. A twodecade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet Lond Engl 2013;382:1405–12. doi:10.1016/S0140-6736(13)61570-6.

    Article  Google Scholar 

  10. Lobo A, Saz P, Marcos G, Dia JL, De-la-Camara C, Ventura T, et al. Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project. Acta Psychiatr Scand 2007;116:299–307. doi:10.1111/j.1600-0447.2007.01006.x.

    Article  CAS  PubMed  Google Scholar 

  11. Schrijvers EMC, Verhaaren BFJ, Koudstaal PJ, Hofman A, Ikram MA, Breteler MMB. Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology 2012;78:1456–63. doi:10.1212/ WNL.0b013e3182553be6.

    Article  CAS  PubMed  Google Scholar 

  12. Qiu C, von Strauss E, Bäckman L, Winblad B, Fratiglioni L. Twentyyear changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 2013;80:1888–94. doi:10.1212/ WNL.0b013e318292a2f9.

    Article  PubMed  Google Scholar 

  13. Christensen K, Thinggaard M, Oksuzyan A, Steenstrup T, Andersen-Ranberg K, Jeune B, et al. Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet Lond Engl 2013;382:1507–13. doi:10.1016/S0140-6736(13)60777-1.

    Article  Google Scholar 

  14. Chibnik LB, Wolters FJ, Bäckman K, Beiser A, Berr C, Bis JC, et al. Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium. Eur J Epidemiol 2017;32:931–8. doi:10.1007/s10654-017-0320-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Rosenberg RN, Lambracht-Washington D, Yu G, Xia W. Genomics of Alzheimer Disease: A Review. JAMA Neurol 2016;73:867–74. doi:10.1001/ jamaneurol.2016.0301.

    Article  PubMed  Google Scholar 

  16. Giri M, Zhang M, Lü Y. Genes associated with Alzheimer’s disease: an overview and current status. Clin Interv Aging 2016;11:665–81. doi:10.2147/ CIA.S105769.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Nagai M, Hoshide S, Dote K, Kario K. Visit-to-visit blood pressure variability and dementia: Blood pressure variability and dementia. Geriatr Gerontol Int 2015;15:26–33. doi:10.1111/ggi.12660.

    Article  PubMed  Google Scholar 

  18. Cowppli-Bony P, Dartigues J-F, Orgogozo J-M. Facteurs de risque vasculaire et risque de maladie d’Alzheimer: revue d’études épidémiologiques. Psychol Neuropsychiatr Vieil 2006;4:47–60.

    PubMed  Google Scholar 

  19. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011;10:819–28. doi:10.1016/ S1474-4422(11)70072-2.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4:487–99. doi:10.1016/ S1474-4422(05)70141-1.

    Article  PubMed  Google Scholar 

  21. Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, et al. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertens Dallas Tex 1979 2016;68:e67–94. doi:10.1161/HYP.0000000000000053.

    CAS  Google Scholar 

  22. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011;10:819–28. doi:10.1016/ S1474-4422(11)70072-2.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Aldrugh S, Sardana M, Henninger N, Saczynski JS, McManus DD. Atrial fibrillation, cognition and dementia: A review. J Cardiovasc Electrophysiol 2017;28:958–65. doi:10.1111/jce.13261.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wolters FJ, Segufa RA, Darweesh SKL, Bos D, Ikram MA, Sabayan B, et al. Coronary heart disease, heart failure, and the risk of dementia: A systematic review and meta-analysis. Alzheimers Dement J Alzheimers Assoc 2018. doi:10.1016/j.jalz.2018.01.007.

    Google Scholar 

  25. Alosco ML, Hayes SM. Structural brain alterations in heart failure: a review of the literature and implications for risk of Alzheimer’s disease. Heart Fail Rev 2015;20:561–71. doi:10.1007/s10741-015-9488-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Hu Q, Teng W, Li J, Hao F, Wang N. Homocysteine and Alzheimer’s Disease: Evidence for a Causal Link from Mendelian Randomization. J Alzheimers Dis 2016;52:747–56. doi:10.3233/JAD-150977.

    Article  CAS  PubMed  Google Scholar 

  27. Morris MS. Homocysteine and Alzheimer’s disease. Lancet Neurol 2003;2:425–428.

    Article  CAS  PubMed  Google Scholar 

  28. Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health 2014;14:643. doi:10.1186/1471-2458-14-643.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kivipelto M, Solomon A. Cholesterol as a risk factor for Alzheimer’s disease–epidemiological evidence. V 2006;114:50–57.

    Google Scholar 

  30. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and metaanalysis. Lancet Neurol 2009;8:1006–1018.

    Article  PubMed  Google Scholar 

  31. Akoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A, Hofman A, et al. Association of Cerebral Microbleeds With Cognitive Decline and Dementia. JAMA Neurol 2016;73:934. doi:10.1001/jamaneurol.2016.1017.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Nagai M, Hoshide S, Kario K. Hypertension and Dementia. Am J Hypertens 2010;23:116–24. doi:10.1038/ajh.2009.212.

    Article  PubMed  Google Scholar 

  33. Miida T. Can statin therapy really reduce the risk of Alzheimer’s disease and slow its progression? 2005.

    Google Scholar 

  34. Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health 2014;14.

    Google Scholar 

  35. Wheeler MJ, Dempsey PC, Grace MS, Ellis KA, Gardiner PA, Green DJ, et al. Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health. Alzheimers Dement NYN 2017;3:291–300. doi:10.1016/j.trci.2017.04.001.

    Google Scholar 

  36. Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009;17:542–555.

    Article  PubMed  Google Scholar 

  37. Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement 2017;13:406–18. doi:10.1016/j.jalz.2016.07.152.

    Article  PubMed  Google Scholar 

  38. Caamaño-Isorna F, Corral M, Montes-Martínez A, Takkouche B. Education and Dementia: A Meta-Analytic Study. Neuroepidemiology 2006;26:226–32. doi:10.1159/000093378.

    Article  PubMed  Google Scholar 

  39. Zhu X, Zhao Y. Sleep-disordered breathing and the risk of cognitive decline: a meta-analysis of 19,940 participants. Sleep Breath 2018;22:165–73. doi:10.1007/ s11325-017-1562-x.

    Article  PubMed  Google Scholar 

  40. Honjo K, van Reekum R, Verhoeff NPLG. Alzheimer’s disease and infection: Do infectious agents contribute to progression of Alzheimer’s disease? Alzheimers Dement 2009;5:348–60. doi:10.1016/j.jalz.2008.12.001.

    Article  PubMed  Google Scholar 

  41. Doulberis M, Kotronis G, Thomann R, Polyzos SA, Boziki M, Gialamprinou D, et al. Review: Impact of Helicobacter pylori on Alzheimer’s disease: What do we know so far? Helicobacter 2018;23:e12454. doi:10.1111/hel.12454.

    Article  Google Scholar 

  42. Tolppanen A-M, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and Alzheimer’s disease: evidence from epidemiological studies. J Alzheimers Dis 2012;32:531–540.

    Article  PubMed  Google Scholar 

  43. Zhang J, Chen C, Hua S, Liao H, Wang M, Xiong Y, et al. An updated metaanalysis of cohort studies: Diabetes and risk of Alzheimer’s disease. Diabetes Res Clin Pract 2017;124:41–7. doi:10.1016/j.diabres.2016.10.024.

    Article  PubMed  Google Scholar 

  44. Alagiakrishnan K, Sankaralingam S, Ghosh M, Mereu L, Senior P. Antidiabetic Drugs and Their Potential Role in Treating Mild Cognitive Impairment and Alzheimer’s Disease. Discov Med 2013;16:277–86.

    PubMed  Google Scholar 

  45. Wenshan L, Du N, Fan X, Wang Y, Jia X, Hou X, et al. Low Testosterone Level and Risk of Alzheimer’s Disease in the Elderly Men: a Systematic Review and Meta-Analysis. Mol Neurobiol 2016;53:2679–84. doi:10.1007/s12035-015-9315-y.

    Article  CAS  Google Scholar 

  46. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and Risk for Alzheimer Disease: Systematic Review, Meta-analysis, and Metaregression Analysis. Arch Gen Psychiatry 2006;63:530. doi:10.1001/ archpsyc.63.5.530.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Harrington KD, Lim YY, Gould E, Maruff P. Amyloid-beta and depression in healthy older adults: a systematic review. Aust NZJ Psychiatry 2015;49:36–46.

    Article  Google Scholar 

  48. Billioti de Gage S, Pariente A, Bégaud B. Is there really a link between benzodiazepine use and the risk of dementia? Expert Opin Drug Saf 2015;14:733–47. doi:10.1517/14740338.2015.1014796.

    Article  CAS  PubMed  Google Scholar 

  49. Panza F, Solfrizzi V, Logroscino G. Age-related hearing impairment - a risk factor and frailty marker for dementia and AD. Nat Rev Neurol 2015;11:166–175.

    Article  PubMed  Google Scholar 

  50. Zheng Y, Fan S, Liao W, Fang W, Xiao S, Liu J. Hearing impairment and risk of Alzheimer’s disease: a meta-analysis of prospective cohort studies. Neurol Sci 2017;38:233–9. doi:10.1007/s10072-016-2779-3.

    Article  PubMed  Google Scholar 

  51. Mortimer JA, Van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al. Head trauma as a risk factor for Alzheimer’s disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20:S28–S35.

    Article  PubMed  Google Scholar 

  52. Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A. Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication. V 2003;74:857–862.

    CAS  Google Scholar 

  53. LaRoia H, Louis ED. Association between Essential Tremor and Other Neurodegenerative Diseases: What Is the Epidemiological Evidence? Neuroepidemiology 2011;37:1–10. doi:10.1159/000328866.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Seitz DP, Shah PS, Herrmann N, Beyene J, Siddiqui N. Exposure to general anesthesia and risk of Alzheimer’s disease: a systematic review and metaanalysis. BMC Geriatr 2011;11:83.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Hug K, Röösli M, Rapp R. Magnetic field exposure and neurodegenerative diseases–recent epidemiological studies. Soz-Präventivmedizin SPM 2006;51:210–20. doi:10.1007/s00038-006-5096-4.

    Article  Google Scholar 

  56. Garcia AM, Sisternas A, Hoyos SP. Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis. Int J Epidemiol 2008;37:329–40. doi:10.1093/ije/dym295.

    Article  PubMed  Google Scholar 

  57. Maes A, Verschaeve L. Can cytogenetics explain the possible association between exposure to extreme low-frequency magnetic fields and Alzheimer’s disease?: Electromagnetic fields and Alzheimer’s disease? J Appl Toxicol 2012;32:81–7. doi:10.1002/jat.1724.

    Article  CAS  PubMed  Google Scholar 

  58. Jalilian H, Teshnizi SH, Röösli M, Neghab M. Occupational exposure to extremely low frequency magnetic fields and risk of Alzheimer disease: A systematic review and meta-analysis. NeuroToxicology 2017. doi:10.1016/j. neuro.2017.12.005.

    Google Scholar 

  59. Yan D, Zhang Y, Liu L, Yan H. Pesticide exposure and risk of Alzheimer’s disease: a systematic review and meta-analysis. Sci Rep 2016;6:32222. doi:10.1038/srep32222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Virk SA, Eslick GD. Brief Report: Meta-analysis of Antacid Use and Alzheimer’s Disease. Epidemiology 2015;26:769–73. doi:10.1097/ EDE.0000000000000326.

    Article  PubMed  Google Scholar 

  61. Flaten TP. Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res Bull 2001;55:187–196.

    Article  CAS  PubMed  Google Scholar 

  62. Doets EL, van Wijngaarden JP, Szczecinska A, Dullemeijer C, Souverein OW, Dhonukshe-Rutten RAM, et al. Vitamin B12 intake and status and cognitive function in elderly people. Epidemiol Rev 2013;35:2–21. doi:10.1093/epirev/ mxs003.

    Article  PubMed  Google Scholar 

  63. Loef M, von Stillfried N, Walach H. Zinc diet and Alzheimer’s disease: a systematic review. Nutr Neurosci 2012;15:2–12. doi:10.1179/147683051 2Y.0000000010.

    Article  CAS  PubMed  Google Scholar 

  64. Du K, Liu M, Pan Y, Zhong X, Wei M. Association of Serum Manganese Levels with Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Nutrients 2017;9:231. doi:10.3390/ nu9030231.

    Article  CAS  PubMed Central  Google Scholar 

  65. Veronese N, Zurlo A, Solmi M, Luchini C, Trevisan C, Bano G, et al. Magnesium Status in Alzheimer’s Disease: A Systematic Review. Am J Alzheimers Dis Dementias® 2016;31:208–13. doi:10.1177/1533317515602674.

    Article  Google Scholar 

  66. van de Rest O, Berendsen AA, Haveman-Nies A, de Groot LC. Dietary Patterns, Cognitive Decline, and Dementia: A Systematic Review. Adv Nutr Int Rev J 2015;6:154–68. doi:10.3945/an.114.007617.

    Article  Google Scholar 

  67. Yusufov M, Weyandt LL, Piryatinsky I. Alzheimer’s disease and diet: a systematic review. Int J Neurosci 2017;127:161–75. doi:10.3109/00207454.2016. 1155572.

    Article  PubMed  Google Scholar 

  68. Cederholm T, Salem N, Palmblad J. -3 Fatty Acids in the Prevention of Cognitive Decline in Humans. Adv Nutr Int Rev J 2013;4:672–6. doi:10.3945/ an.113.004556.

    Article  CAS  Google Scholar 

  69. Jiang C, Li G, Huang P, Liu Z, Zhao B. The Gut Microbiota and Alzheimer’s Disease. J Alzheimers Dis JAD 2017;58:1–15. doi:10.3233/JAD-161141.

    Article  CAS  PubMed  Google Scholar 

  70. Yuan Q, Wang C-W, Shi J, Lin Z-X. Effects of Ginkgo biloba on dementia: An overview of systematic reviews. J Ethnopharmacol 2017;195:1–9. doi:10.1016/j. jep.2016.12.005.

    Article  CAS  PubMed  Google Scholar 

  71. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, et al. Vitamin D, cognition, and dementia A systematic review and meta-analysis. Neurology 2012;79:1397–1405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, et al. Plasma nutrient status of patients with Alzheimer’s disease: Systematic review and meta-analysis. Alzheimers Dement J Alzheimers Assoc 2014;10:485–502. doi:10.1016/j.jalz.2013.05.1771.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Univ. Lille, F-59000, Lille, France

    Michaël Rochoy, V. Rivas, E. Chazard, E. Decarpentry, G. Saudemont, P.-A. Hazard, F. Puisieux, S. Gautier & R. Bordet

  2. INSERM, U1171-Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France

    Michaël Rochoy, S. Gautier & R. Bordet

  3. EA2694, Public Health Department, Univ Lille, CHU Lille, F-59000, Lille, France

    E. Chazard

  4. 20 rue André Pantigny, 62230, Outreau, France

    Michaël Rochoy

Authors
  1. Michaël Rochoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Rivas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Chazard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Decarpentry
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Saudemont
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P.-A. Hazard
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Puisieux
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Gautier
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R. Bordet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michaël Rochoy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rochoy, M., Rivas, V., Chazard, E. et al. Factors Associated with Alzheimer’s Disease: An Overview of Reviews. J Prev Alzheimers Dis 6, 121–134 (2019). https://doi.org/10.14283/jpad.2019.7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.14283/jpad.2019.7

Key words

Search

Navigation